Arch Capital Group (NASDAQ:ACGL) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.06 by 26.42 percent. This is a 34 percent increase over earnings of $1.00 per share from the same period last year.
What’s Going On With Clinical-Stage Biotech Firm NeuroBo Shares Today?
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares are trading lower in Friday's premarket session after ending Thursday's session with a whopping 21.2% gain.
